This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GILLIES, G. Articles by LOWRY, P. J. Search for Related Content PubMed PubMed Citation Articles by GILLIES, G. Articles by LOWRY, P. J.

Characterization of Rat Stalk Median Eminence Vasopressin and Its Involvement in Adrenocorticotropin Release

Pituitary Hormone Laboratory, Department of Chemical Pathology, St. Bartholomew's Hospital London, England
the Rudolf Magnus Institute for Pharmacology (Tj.B.V.W.G.), University of Utrecht The Netherlands

Address requests for reprints to: Dr. Glenda Gillies, St. Bartholomew's Hospital, Pituitary Hormone Laboratory, Department of Chemical Pathology, 51–53 Bartholomew Close, London EC1A 7BE, England.

Abstract

The perfused isolated rat anterior pituitary cell column was used as a bioassay for corticotropinreleasing factor (CRF). The system responded to arginine vasopressin (AVP) in a dose-dependent manner with a minimum effective dose of 10^-10 M. Log doseresponse curves for AVP and crude stalk median eminence extract (SME) were statistically significantly nonparallel (P < 0.05) and similar results were found for lysine vasopressin, arginine vasotocin (AVT), oxytocin, and human posterior lobe extract. Vasopressin and its analogs had no effect on LH release. Using RIA for AVP, SME was found to contain 10.83 ng (7.7–14.3 ng, n = 12) AVP, which could account for no more than 30% of its CRF activity. The CRF activity of both SME and AVP was totally quenched by incubation overnight with vasopressin antisera. Partial quenching was obtained with higher dilutions of the antisera. Vasopressin-stimulated ACTH release was affected in a similar way to SME-stimulated ACTH release by the presence of corticosterone (0.2 µg/ml) in the perfusate, by removal of calcium and magnesium ions from the perfusate, and by treatment of AVP or SME with trypsin. These results suggest that the CRF activity of our extract is due to a peptide with a vasopressin-like structure.

Received August 16, 1977.

This article has been cited by other articles:

				H. Orcel, V. A. Tobin, G. Alonso, and A. Rabie Immunocytochemical Localization of Vasopressin V1a Receptors in the Rat Pituitary Gonadotropes Endocrinology, November 1, 2002; 143(11): 4385 - 4388. [Abstract] [Full Text] [PDF]

				C Rivier, J Rivier, and W Vale Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor Science, October 22, 1982; 218(4570): 377 - 379. [Abstract] [PDF]